Sam Brusco, Associate Editor11.13.23
Inogen, a company that offers respiratory products for the homecare setting, has appointed Kevin Smith as its new president and CEO, as well as a member of its board. This is effective immediately; Smith succeeds Nabil Shabshab.
Smith has over 20 years of experience of leadership experience in the medical device industry, include respiratory care and durable medical equipment businesses. He was most recently CEO of Sirtex Medical, maker of interventional treatment products.
Before Sirtex, he held senior positions at Sensium Healthcare, Teleflex, Hillrom, and ZOLL Medical.
Smith told the press, “I am honored to join Inogen, a company with a strong brand, global reach, and purpose-led vision. I believe Inogen has a solid foundation, with leading products, and significant potential to make innovative respiratory solutions the standard of care to improve patient health. I look forward to working with the Board and entire team to drive growth, innovation, and enhanced performance to create value for patients and our shareholders alike.”
“Inogen is a global leader in portable oxygen therapy solutions, with a large and growing market, and leading patient-centric product portfolio,” said Elizabeth Mora, chairperson of the board. “We believe we have tremendous opportunities to scale our business, drive operational efficiencies and accelerate our growth trajectory, and the Board believes it is the right time for new leadership to improve performance and support Inogen’s next phase of its journey. With deep global medical device experience and a strong track record of successful business transformations, we believe Kevin is the right leader to capitalize on Inogen’s potential. We look forward to benefitting from his expertise as we seek to advance our commercial strategy, win new customers, and drive sustainable, long-term value for our shareholders.”
Earlier this month, the company appointed Mike Sergesketter as interim chief financial officer (CFO) to succeed Kristin Caltrider, who stepped down for personal reasons.
Smith has over 20 years of experience of leadership experience in the medical device industry, include respiratory care and durable medical equipment businesses. He was most recently CEO of Sirtex Medical, maker of interventional treatment products.
Before Sirtex, he held senior positions at Sensium Healthcare, Teleflex, Hillrom, and ZOLL Medical.
Smith told the press, “I am honored to join Inogen, a company with a strong brand, global reach, and purpose-led vision. I believe Inogen has a solid foundation, with leading products, and significant potential to make innovative respiratory solutions the standard of care to improve patient health. I look forward to working with the Board and entire team to drive growth, innovation, and enhanced performance to create value for patients and our shareholders alike.”
“Inogen is a global leader in portable oxygen therapy solutions, with a large and growing market, and leading patient-centric product portfolio,” said Elizabeth Mora, chairperson of the board. “We believe we have tremendous opportunities to scale our business, drive operational efficiencies and accelerate our growth trajectory, and the Board believes it is the right time for new leadership to improve performance and support Inogen’s next phase of its journey. With deep global medical device experience and a strong track record of successful business transformations, we believe Kevin is the right leader to capitalize on Inogen’s potential. We look forward to benefitting from his expertise as we seek to advance our commercial strategy, win new customers, and drive sustainable, long-term value for our shareholders.”
Earlier this month, the company appointed Mike Sergesketter as interim chief financial officer (CFO) to succeed Kristin Caltrider, who stepped down for personal reasons.